Cover Image
市場調查報告書

血栓管理設備的美國市場

US Clot Management Devices Market - 2016

出版商 iData Research Inc. 商品編碼 347788
出版日期 內容資訊 英文 53 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
血栓管理設備的美國市場 US Clot Management Devices Market - 2016
出版日期: 2015年11月01日 內容資訊: 英文 53 Pages
簡介

所謂肺栓塞症,是血栓從人體其他部位朝肺的內部移動、集積,阻塞肺動脈的疾病,美國每年有60萬人以上發病。抗凝固療法成為治療方法的第一選項,不過,也有第二選項,用下腔靜脈濾器 (IVCF) 和血栓去除裝置,去除肺動脈血栓的方法。這2個治療方法中,血栓去除裝置,尤其是動靜脈 (AV) 進入設備成為最成熟的治療方法。

本報告提供美國的血栓管理設備 (血栓去除裝置、下腔靜脈濾器) 的市場相關分析、各產品市場結構和最新趨勢、市場整體及產品單位的市場趨勢預測、主要的推動及阻礙市場要素、市場競爭情形等調查評估。

目錄

圖表一覽

摘要整理

分析方法

  • 分析範圍
  • iDATA的9階段分析方法

血栓去除裝置市場

  • 簡介
    • 其他末稍血管的血栓去除裝置的利用
  • 市場概況
  • 市場分析與預測
    • 血栓去除裝置市場整體
    • 動靜脈 (AV) 進入用血栓去除裝置市場
    • 動脈、靜脈用血栓去除裝置市場
  • 推動及阻礙市場要素
    • 推動市場要素
    • 阻礙市場要素
  • 競爭分析

下腔靜脈濾器 (IVCF) 市場

  • 簡介
  • 市場概況
  • 市場分析與預測
    • IVCF市場整體
    • 非永久式IVCF市場
    • 永久留置式IVCF市場
  • 推動及阻礙市場要素
    • 推動市場要素
    • 阻礙市場要素
  • 競爭分析

簡稱集

目錄
Product Code: iDATA_USCMD16_RPT

The total thrombectomy device market comprises thrombectomy devices used in arteriovenous (AV) access thrombectomy procedures, arterial thrombectomy procedures and venous thrombectomy procedures. The market for thrombectomy devices used in AV access thrombectomy procedures is mature relative to the market for thrombectomy devices used in arterial and venous thrombectomy procedures.

Pulmonary embolism is a condition that affects over 600,000 individuals each year in the U.S. and leads to mortality in almost a third of those afflicted. This condition is caused by the accumulation of dislodged bodies in the lungs. These usually originate from blood clots or thrombi from a deep vein in the leg. Inferior vena cava filters (IVCFs) prevent pulmonary embolism by intercepting a thrombus before it can enter the circulatory system of the lungs.

The market for thrombectomy devices used in AV access thrombectomy procedures is mature relative to the market for thrombectomy devices used in arterial and venous thrombectomy procedures. The thrombectomy devices utilized in arterial and venous thrombectomy procedures are more sophisticated than the thrombectomy devices utilized in AV access thrombectomy procedures and therefore command a higher ASP.

Although anticoagulation therapy remains the first-line treatment for pulmonary embolism, IVCF unit sales are expected to increase over the forecast period. IVCFs can be classified as permanent or retrievable.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 THROMBECTOMY DEVICE MARKET
  • 1.2 INFERIOR VENA CAVA FILTER MARKET

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

THROMBECTOMY DEVICE MARKET

  • 3.1 INTRODUCTION
    • 3.1.1 Other Peripheral Applications of Thrombectomy Devices
  • 3.2 MARKET OVERVIEW
  • 3.3 MARKET ANALYSIS AND FORECAST
    • 3.3.1 Total Thrombectomy Device Market
    • 3.3.2 Arteriovenous (AV) Access Thrombectomy Device Market
    • 3.3.3 Arterial & Venous Thrombectomy Device Market
  • 3.4 DRIVERS AND LIMITERS
    • 3.4.1 Market Drivers
    • 3.4.2 Market Limiters
  • 3.5 COMPETITIVE ANALYSIS

INFERIOR VENA CAVA FILTER MARKET

  • 4.1 INTRODUCTION
  • 4.2 MARKET OVERVIEW
  • 4.3 MARKET ANALYSIS AND FORECAST
    • 4.3.1 Total Inferior Vena Cava Filter Market
    • 4.3.2 Retrievable Inferior Vena Cava Filter Market
    • 4.3.3 Permanent Inferior Vena Cava Filter Market
  • 4.4 DRIVERS AND LIMITERS
    • 4.4.1 Market Drivers
    • 4.4.2 Market Limiters
  • 4.5 COMPETITIVE ANALYSIS

ABBREVIATIONS

Back to Top